Heterocyclic compounds as modulators of TNFα activity
TW202629565APending Publication Date: 2026-07-16SYNNOVATION THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114136178
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-09
- Filing Date
- 2025-09-19
- Publication Date
- 2026-07-16
Abstract
The present application provides heterocyclic compounds that modulate the activity of tumor necrosis factor-alpha (TNFα), which are useful in the treatment of various diseases, including autoimmune diseases and inflammatory diseases.
Need to check novelty before this filing date? Find Prior Art